Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

846 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.
Takasaka N, Hosaka Y, Fukuda T, Shinfuku K, Chida K, Shibata S, Kojima A, Hasegawa T, Yamada M, Yamanaka Y, Seki A, Seki Y, Ishikawa T, Kuwano K. Takasaka N, et al. Among authors: chida k. Respir Med. 2022 Feb;192:106738. doi: 10.1016/j.rmed.2022.106738. Epub 2022 Jan 10. Respir Med. 2022. PMID: 35051876 Free article.
Interstitial lung diseases associated with amyopathic dermatomyositis.
Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, Hashimoto D, Sato J, Toyoshima M, Hashizume H, Chida K. Suda T, et al. Among authors: chida k. Eur Respir J. 2006 Nov;28(5):1005-12. doi: 10.1183/09031936.06.00038806. Epub 2006 Jul 12. Eur Respir J. 2006. PMID: 16837503 Free article.
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial.
Taniguchi H, Kondoh Y, Ebina M, Azuma A, Ogura T, Taguchi Y, Suga M, Takahashi H, Nakata K, Sato A, Sugiyama Y, Kudoh S, Nukiwa T; Pirfenidone Clinical Study Group in Japan. Taniguchi H, et al. Respir Res. 2011 Jul 15;12(1):93. doi: 10.1186/1465-9921-12-93. Respir Res. 2011. PMID: 21756364 Free PMC article. Clinical Trial.
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment.
Azuma A, Taguchi Y, Ogura T, Ebina M, Taniguchi H, Kondoh Y, Suga M, Takahashi H, Nakata K, Sato A, Kudoh S, Nukiwa T; Pirfenidone Clinical Study Group in Japan. Azuma A, et al. Respir Res. 2011 Oct 28;12(1):143. doi: 10.1186/1465-9921-12-143. Respir Res. 2011. PMID: 22035508 Free PMC article. Clinical Trial.
Bronchiolar disease in rheumatoid arthritis.
Hayakawa H, Sato A, Imokawa S, Toyoshima M, Chida K, Iwata M. Hayakawa H, et al. Among authors: chida k. Am J Respir Crit Care Med. 1996 Nov;154(5):1531-6. doi: 10.1164/ajrccm.154.5.8912776. Am J Respir Crit Care Med. 1996. PMID: 8912776
[Pulmonary cryptococcosis exhibiting diffuse multiple nodular shadows].
Inui N, Chida K, Suda T, Toyoshima M, Todate A, Ide K, Tsukamoto K, Sato J, Tsuchiya T, Nakamura H. Inui N, et al. Among authors: chida k. Nihon Kokyuki Gakkai Zasshi. 1998 Dec;36(12):1038-42. Nihon Kokyuki Gakkai Zasshi. 1998. PMID: 10064958 Japanese.
846 results